INDOFREBIO

Indo French Biotech Enterprises Ltd Share Price

₹00.00 0.00 (0.00%)

21 Nov, 2024 14:07

SIP TrendupStart SIP in INDOFREBIO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

SIP Lightning

Smart Investing Starts Here Start SIP with Indo French Biotech Enterprises Ltd for Steady Growth!

Invest Now

Indo French Biotech Enterprises Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 0
  • P/B Ratio
  • -
  • Average True Range
  • -
  • EPS
  • -
  • Dividend Yield
  • -
  • MACD Signal
  • -
  • RSI
  • -
  • MFI
  • -

Indo French Biotech Enterprises Ltd Financials

Indo French Biotech Enterprises Ltd Technicals

EMA & SMA

Current Price
₹00.00
(%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

00 Pivot Speed

What's your outlook on Indo French Biotech Enterprises Ltd?

You can only vote for once

Indo French Biotech Enterprises Ltd F&O

Indo French Biotech Enterprises Ltd Shareholding Pattern

No data available.

About Indo French Biotech Enterprises Ltd

  • NSE Symbol
  • INDOFREBIO
  • BSE Symbol
  • 519538
  • ISIN
  • INE867B01012

Similar Stocks to Indo French Biotech Enterprises Ltd

Indo French Biotech Enterprises Ltd FAQs

Indo French Biotech Enterprises Ltd share price is ₹00 As on 21 November, 2024 | 13:53

The Market Cap of Indo French Biotech Enterprises Ltd is ₹ Cr As on 21 November, 2024 | 13:53

The P/E ratio of Indo French Biotech Enterprises Ltd is As on 21 November, 2024 | 13:53

The PB ratio of Indo French Biotech Enterprises Ltd is As on 21 November, 2024 | 13:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23